Final Agenda

NATIONAL COMMITTEE ON VITAL AND HEALTH STATISTICS

Subcommittee on Standards and Security

May 25-27, 2004

Hubert H. Humphrey Building , Room 505-A
200 Independence Avenue SW
Washington , DC 20201

Meeting Minutes

Tuesday, May 25

Transcript
9:15 a.m. Call to OrderWelcome and Introductions Simon Cohn, M.D.
9:30 a.m. E-rx Networks Kevin Hutchinson, SureScriptsJim Bradley, RxHub

Richard Brook, ProxyMed
11:20 a.m. Break
11:40 a.m. Findings From RAND Study on E-Prescribing Douglas Bell, M.D., Ph.D.
12:15 p.m. Lunch
1:15 p.m. Patient Safety and E-Prescribing David Bates, M.D.
2:00 p.m. Break
2:30 p.m. State of the Art of E-Prescribing Implementation Robin Thomashauer, CAQHDavid Medvedeff, Pharm.D., Gold Standard Multimedia

Robert Mandel, M.D., BC/BS of Massachusetts
Article

Laura Adams, RI Quality Institute
4:10 p.m. Break
4:30 p.m. Open Microphone
5:15 p.m. Subcommittee Discussion
6:00 p.m. Adjourn
Wednesday, May 26

Transcript
8:40 a.m. Call to OrderWelcome and Introductions Simon Cohn, M.D.
8:55 a.m. E-Prescribing: The Software Vendors Perspective Tom Doerr, WellinxJohn Faughnan, M.D., M.S. McKesson Provider Technologies

Peter Kaufman, M.D., DrFirst

Jill Helm and Larry Trusky, AllScripts

Rohit Nayak, MedPlus, Inc.

Daniel S. Nutkis, Zix Corp.
10:45 a.m. Break
11:00 a.m. E-Prescribing: The Software Vendors Perspective (Cont’d) Discussion
12:15 p.m. Lunch
1:25 p.m. E-Prescribing: The Drug Knowledge Base Vendors George Robinson and Tom Bizzaro, First DataBank, Inc.Mark Millikan, Pharm.D., MBA, MediSpan

Gerry Hobson, Multum
2:45 p.m. Break
3:00 p.m. Open Microphone
3:05 p.m. Follow-up on HIPAA Implementation Issues Ed Jones, Jim Daley, Jim Schuping, and Steve Lazarus,WEDI
4:15 p.m. Follow-up on DSMO Request Donna Pickett, NCHS, CDC
4:30 p.m. Development of Potential Letter Simon Cohn, M.D.
5:30 p.m. Subcommittee Discussion Simon Cohn, M.D.Jeff Blair
6:00 pm Adjourn
Thursday, May 27

Transcript
8:40 a.m. Call to OrderWelcome and Introductions Simon Cohn, M.D.
8:50 a.m. E-Prescribing: The Provider Perspective Nean Narcissi, AMAPatricia Hale, M.D., Ph.D., ACP

David Kibbe, M.D., AAFP 

Mary Schumann, M.S.N., R.N., ANA
11:15 a.m. Break
11:40 a.m. Open Microphone
12:20 a.m. Subcommittee Discussion Simon Cohn, M.D.Jeff Blair
12:30 p.m. Planning for next meetings Simon Cohn, M.D.
12:40 p.m. Adjourn

Written Only Testimony

e-prescribing WorkPlan 9

06/15/2004

Formal Questions for Hearing

Testimony should be provided in two parts:

  1. Written testimony. The framework for your written testimony is attached. It includes a list of the requirements for e-prescribing standards set forth in the Medicare Prescription Drug, Improvement & Modernization Act with room for your responses. The law includes detailed requirements that we have organized into a set of Basic Requirements [click here to view] and a set of Additional Requirements [click here to view]. Completed spreadsheets should be electronically sent to Maria Friedman at MFriedman@cms.hhs.gov no later than Wednesday, May 19, 2004. Your written testimony should be electronically sent to Marietta Squire at MRawlinson@cdc.gov no later than Wednesday, May 19, 2004.
  2. Oral testimony. Oral testimony will include some highlights which you should derive from your written testimony, plus your responses to a few other questions. Please respond to the following questions within the 20-minute timeframe.
    • What are the best standards or code sets to meet the requirements of the Law? (Oral testimony only needs to focus on the major standards/code sets that you think the NCVHS should consider.)
    • Which of these standards/code sets do you use?
    • What are the strengths and weaknesses of the standards/code sets that you use?
    • Is nationwide adoption of these standards/code sets necessary?
    • What are the e-prescribing standard/code set gaps? (These may be standards/code sets that are needed to address requirements in the law or other functions, but are not yet available.)
    • What are the barriers to the development/adoption of these standards/code sets?
    • What incentives or other suggestions should the government consider to accelerate the development/adoption of e-prescribing standards/code sets?

Industry Stakeholder Responses

Industry stakeholders are also invited to submit information using the attached spreadsheets. The information should be electronically sent to Maria Friedman atMFriedman@cms.hhs.gov no later than Monday, May 31, 2004.

The framework for your written testimony is attached. It includes a list of the requirements for e-prescribing standards set forth in the Medicare Prescription Drug, Improvement & Modernization Act with room for your comments. The law includes detailed requirements that we have organized into a set of Basic Requirements [click here to view] and a set of Additional Requirements [click here to view] and are reflected in the spreadsheets.

Responses received will be aggregated with those received from the formal hearings and will be considered by the Subcommittee.

Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (301) 458-4EEO (4336) as soon as possible.

Times, topics, and speakers are subject to change. For final agenda, please call 301-458-4200 at NCHS or visit the NCVHS Home Page at https://ncvhs.hhs.gov/